News

Symphogen Presents Positive Rozrolimupab (SYM001) Phase 2 Trial Results in ITP at ASH

Symphogen Announces Initiation of Phase 2 Trial of Sym004 EGFR Antibody Mixture in Patients with Squamous Cell Carcinoma of Head and Neck Cancer

Symphogen Presents Preliminary Results from Phase 2 Clinical Trial with Rozrolimupab at the Annual European Hematology Association

Calendar

	Informa Life Sciences, Cell Line Development & Engineering Conference
	Speaker: Christina Andersen, Scientist

• February 13 - 17, 2012 The Radisson Blu Hotel, Cologne, Germany

Cell culture world congress

• February 28 - March 1, 2012 Eurostars Grand Central, Munich, Germany

AACR Annual Meeting 2012

• March 31 - April 4, 2012 Chicago, IL

	5th Annual Proteins Congress
	Speaker: Torben P. Frandsen, Vice President of PreClinical R&D Support

• April 2 - 3, 2012 London

Shortcuts